Friday, 28 Feb 2020

You are here

Systemic JIA-Associated Lung Disease

A disease you’ve never heard of is becoming increasingly common and carries a very poor prognosis. 

For me, one of most important aspects of attending the ACR Annual Meeting is to learn about conditions that I don’t know and that may afflict my patients when I return back home. This year’s meeting was no different.

The disease that caught my attention? Systemic juvenile idiopathic arthritis-associated lung disease (SJIA-LD). This newly-described disease was featured in the Pediatrics Year in Review, as well as in several sessions, abstracts, and study groups. Dr. Grant Schulert and his colleagues at Cincinnati Children’s Hospital have led the efforts to better understand this condition. So what did I learn?

For the adult rheumatologists in the room, SJIA was the original Still’s disease, the pediatric version of what we now call adult onset Still’s disease (SJIA). It is characterized by daily spiking fevers, arthritis, hepatosplenomegaly, lymphadenopathy, and a salmon-colored rash. Up to now, lung disease had not been recognized as a major complication of this condition. 

However, Dr. Schulert and others began seeing patients with SJIA who were developing respiratory symptoms unlike those that had been described previously, and they called this condition SJIA-LD. 

Patients with SJIA-LD typically present with mild dyspnea, a chronic cough, and may even develop clubbing of the fingers. CT imaging findings include pleural, bronchial wall, or peribronchovascular thickening, septal widening, with commonly seen ground glass opacities, lymphadenopathy, and peripheral consolidation. Histopathology reveals lymphoplasmacytic infiltrates and features of pulmonary alveolar proteinosis. Prognosis is poor; studies have shown mortality rates up to 37-68%.

Risk factors for developing SJIA-ILD include an earlier age of SJIA diagnosis, prior episodes of macrophage activation syndrome (MAS), adverse reactions to biologic therapy, and higher serum IL-18 levels. 

The cause of SJIA-ILD remains unclear. It is possible that certain genetic factors or environmental factors such as infections may be playing a role. 

Better understanding of the cause of SJIA-ILD may help to provide us with guidance on its management. I hope that some answers will become available at #ACR20…stay tuned!

Add new comment

More Like This

Bariatric Surgery Improves Rheumatoid Activity

Obesity is a risk factor for the onset of rheumatoid arthritis (RA) and may also an impediment to optimal DMARD and biologic responses.  A new study has shown that after 1 year, obese RA patients undergoing bariatric surgery with weight loss had significantly lower disease activity.

Seronegativity on the Rise in RA

Although the overall incidence rates of rheumatoid arthritis (RA) have remained stable over recent decades, there has been a significant increase in seronegative cases, a retrospective study showed.

Alcohols Net Zero Effect in Rheumatoid Arthritis

A report from The National Databank for Rheumatic Disease addressed the impact of alcohol on disease activity and mortality in rheumatoid arthritis (RA) and found that alcohol use was not associated with changes in disease activity or mortality, after addressing confounders. 

DMARD Inertia by Registry Rheumatologists

A registry study of metric use (primarily RAPID3 and CDAI) in the treatment of rheumatoid arthritis (RA) patients shows that, even in the face of moderate or high disease activity, treatment changes by rheumatologists were relatively low (35.6–54.6%).

Bariatric Weight Loss Fails to Alter RA Risk

Obesity has been shown to be a risk factor for the onset of rheumatoid arthritis (RA) and also shown to affect outcomes by impairing responses to many DMARD therapies. A Swiss study of RA patients undergoing bariatric surgery failed to show that bariatric surgery and weight loss had any effect on the incidence of RA.